Search / 314 results found

  • Posted

Merck and Ridgeback Biotherapeutics now own molnupiravir, and on November 30, a team of infectious disease advisers to the US Food and Drug Administration will look at results of their clinical trial and decide whether to recommend emergency use authorization for the drug to treat early-stage COVID-19.

  • Posted

Pfizer and BioNTech said on Tuesday they're seeking emergency use authorization from the US Food and Drug Administration for a COVID-19 vaccine booster for all individuals age 18 and older. The companies are seeking an amendment to the existing EUA for booster doses for some adults.